| Sep'12 | Jun'12 | Mar'12 | Dec'11 | Sep'11 | Jun'11 | Mar'11 | Sep'10 | Jun'10 |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
22,346 | 19,247 | 16,419 | 19,344 | 21,036 | 17,948 | 0 | 0 | 0 |
Cost of revenue | ||||||||
28,071 | 29,025 | 27,025 | 28,309 | 0 | 0 | 0 | - | - |
Start-up production costs | ||||||||
- | - | - | - | - | - | - | 0 | 0 |
Research and development | ||||||||
34,815 | 35,494 | 34,576 | 32,691 | 29,336 | 24,718 | 0 | 0 | 0 |
Sales and marketing | ||||||||
17,880 | 17,657 | 16,153 | 13,600 | 10,884 | 8,742 | 0 | 0 | 0 |
General and administrative | ||||||||
16,373 | 15,508 | 15,395 | 14,039 | 12,388 | 10,341 | 0 | 0 | 0 |
Restructuring charges | ||||||||
0 | 0 | - | - | - | - | - | - | - |
Total cost and expenses | ||||||||
98,779 | 99,180 | 93,149 | 88,639 | 79,501 | 67,420 | 0 | 0 | 0 |
Loss from operations | ||||||||
-76,433 | -79,933 | -76,730 | -69,295 | -58,465 | -49,472 | 0 | 0 | 0 |
Interest expense | ||||||||
2,956 | 3,081 | 3,156 | 2,732 | 2,857 | 2,891 | 0 | 0 | 0 |
Interest and other income (expense), net | ||||||||
19 | 27 | -233 | -321 | -9,160 | -9,144 | 0 | 0 | 0 |
Net loss | ||||||||
-79,370 | -82,987 | -80,119 | -72,348 | -70,482 | -61,507 | 0 | 0 | 0 |
Deemed dividend related to beneficial conversion feature of Series E convertible preferred stock | ||||||||
- | - | - | - | - | - | - | 0 | - |
Net loss attributed to common stockholders | ||||||||
- | - | - | - | - | - | - | 0 | - |
Net loss per share - basic and diluted | ||||||||
-0.52 | -0.55 | -0.60 | -0.71 | -0.65 | -0.56 | -0.48 | -21.87 | -13.93 |
Weighted-average shares of common stock outstanding used in computing net loss per share - basic and diluted | ||||||||
34,334 | 34,079 | - | - | 33,076 | 28,290 | - | - | - |
Weighted-average shares of common stock outstanding used in computing net loss per share attributed to common stockholders-basic and diluted | ||||||||
- | - | 33,482 | - | - | - | 25,959 | 954 | 907 |
Comprehensive loss | ||||||||
0 | 0 | 0 | - | 0 | 0 | 0 | - | - |